Skip to main content

This job has expired

You will need to login before you can apply for a job.

Quality Assurance Associate, GCP/GLP

Employer
Precision BioSciences, Inc.
Location
Durham, NC, United States
Start date
Jul 8, 2019

View more

Discipline
Quality, Quality Assurance
Required Education
Associate Degree
Position Type
Full time
Hotbed
Bio NC

Job Details

The Quality Assurance Associate, within the Quality and Compliance Team, will report to either the Sr. Director of Quality and Compliance or other senior staff, and receive supervision from the senior members of the team. The QA Associate will help to develop and maintain the Quality Management System through the development, implementation and maintenance of quality standards, policies and procedures. This person will work within the Quality team to ensure compliance with FDA and other regulatory agency requirements, as well as customer and internal company quality systems requirements.

Essential Duties and Responsibilities
  • Perform critical in-phase audits of GLP operations, both internally and externally
  • Perform QA oversight of clinical operations, both remotely and on-site
  • Perform qualification audits of GLP and GCP suppliers
  • Track Quality documents and records (e.g. deviations, CAPAs, documents, audits, approved vendors) to ensure compliance with internal and external requirements
  • Work with Quality team members to develop, implement, and maintain a phase appropriate Quality Management System (QMS) through the creation, review and approval of documentation including policies and standard operating procedures (SOPs). Primary focus will be on GLP and GCP operations
  • Investigate, triage and document quality issues/deviations, and recommend corrective actions/CAPAs related to GLP and GCP issues
  • Work with and assist Quality team members to maintain the internal and external audit programs
  • Participate in regulator and partner audits
  • Assist in training new staff in quality system requirements and applicable regulations
  • Assist QA with other projects and tasks, where applicable

Qualifications
The requirements listed below are representative of the knowledge, skill, and/or ability required to perform this job successfully.

Education/Experience
  • BS or equivalent in life science or related field
  • 2+years industry experience in pre-clinical (GLP) and/or clinical (GCP) Quality Assurance required
  • Knowledge of FDA regulations and standards, especially those pertaining to pre-clinical and clinical research

Language Ability
  • Ability to read, analyze, and interpret common scientific and technical journals, financial reports, and legal documents.
  • Ability to respond to common inquiries or complaints from customers, regulatory agencies, or members of the business community.

Computer Skills
  • To perform this job successfully, an individual should have knowledge of Microsoft Office software suite.

Physical Demands

The physical demands described here are representative of those that must be met by an employee to successfully perform the essential functions of this job.
  • The employee must occasionally lift and/or move up to 25 pounds.
  • Specific vision abilities required by this job include close vision, color vision, peripheral vision and ability to adjust focus.
  • While performing the duties of this job, the employee is frequently required to stand; walk; sit; use hands to handle or feel and talk or hear.
  • The employee is occasionally required to reach with hands and arms; climb or balance; stoop, kneel, crouch, or crawl and taste or smell.

Travel Requirements
  • This position requires up to 15% travel.

Precision BioSciences mission and vision is to translate the worlds most powerful genome editing technology into greatly needed products throughout the life sciences, by being the conduit through which the greatest genome engineering challenges are solved. Precisions wholly proprietary ARCUS genome editing platform enables the production of highly specific nucleases that can insert, remove, and modify DNA at essentially any location in a complex genome. Through our ARCUS platform, we are developing genome editing-based products to address critical needs in oncology, genetic disease, agriculture, and beyond. For additional information, please visit www.precisionbiosciences.com

Precision BioSciences provides equal employment opportunities (EEO) to all employees and applicants for employment without regard to race, color, religion, gender, sexual orientation, gender identity or expression, national origin, age, disability, genetic information, marital status, amnesty, or status as a covered veteran in accordance with applicable federal, state and local laws. Precision BioSciences complies with applicable state and local laws governing non-discrimination in employment in every location in which the company has facilities. This policy applies to all terms and conditions of employment, including, but not limited to, hiring, placement, promotion, termination, layoff, recall, transfer, leaves of absence, compensation, and training.

Company

Precision BioSciences, Inc. (Nasdaq: DTIL) is a clinical stage gene editing company developing in vivo gene editing and ex vivo allogeneic CAR T therapies with its highly precise and versatile ARCUS genome editing platform. ARCUS uses sequence-specific DNA-cutting enzymes, or nucleases designed for gene knock out, as well as highly sophisticated edits for gene insertion and/or gene repair. Precision’s in vivo gene editing pipeline consists of wholly-owned preclinical candidates for primary hyperoxaluria type 1 (PBGENE-PH1), familial hypercholesteremia (PBGENE-PCSK9) and chronic hepatitis B (PBGENE-HBV). It has also partnered with Lilly to develop candidates for Duchenne muscular dystrophy and two other programs targeting the liver and CNS. Precision’s allogeneic CAR T pipeline consists of multiple investigational candidates in early-stage clinical trials, including its first and second generation CD19 targeting candidates PBCAR0191 and PBCAR19B for relapsed and/or refractory (R/R) non-Hodgkin and B-cell lymphoma patients. Precision has also prioritized development of PBCAR269A, its BCMA targeted candidate in combination with a gamma secretase inhibitor for R/R patients with multiple myeloma. Precision BioSciences and its in-house manufacturing facility for AAV, mRNA, and CAR T cells is based in Durham, North Carolina. For more information about Precision BioSciences please visit www.precisionbiosciences.com

Stock Symbol: DTIL

Stock Exchange: NASDAQ

Company info
Website
Phone
919-314-5512
Location
302 East Pettigrew Street
Durham
North Carolina
27701
US

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert